<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Lucira Health</title>
  <description>Debkishora Mitra and John Waldeisen are the co-founders of Lucira Health.  Lucira Health, which was originally founded as Diassess, is the first company to get an FDA approval for at-home PCR based test for COVID. We talk about the story of Lucira from its founding stage to raising; the technological and market based pivots; raising over $250M (including an IPO); COVID; leadership transition; regulatory affairs; ups and downs of the journey; FDA approval of at-home flu and covid test and the unfortunate bankruptcy.  Shownotes: -&amp;amp;nbsp;https://www.lucirahealth.com  - Educational backgrounds of the founders &amp;amp;amp; how they met - Market exploration in search of billion dollar markets: markets for diseases like Malaria not big enough (~$50M) - Technology development: Disposable RT PCR; Passive Fluid actuation; Colorimetric PCR- Visible DNA amplification - Deborah Dean, MD, UCSF - Running PCR in the second bedroom at home; struggling to pay rent - Raising seed round - Visa struggles- Detour to deal with immigration struggles - Growing the team; mistakes - Transparency, radical candor - Ego - Fundraising: Kissing the frogs; building soft circles - Diagnostics market is super hard - Non-dilutive funding; mental models - Venture capital: Lessons learned - Pivots: Technological and market driven (STD, flu, COVID) - Challenges: Regulatory, customer centric thinking, scalability (manufacturing, distribution) - Deep dive into regulatory challenges: Issues with comparing with predicates - &amp;quot;In the diagnostic space, 'you don't want to be the first in the market&amp;quot; - Selecting an advisor to provide regulatory guidance for a startup - Deep dive into product development - Understanding the value of luck: Having a plan B - Evolution of the &amp;quot;Go to market&amp;quot; strategy - Government policies: Macroeconomic factors that affect pricing for startups - Create options as the CEO - Building the narrative - Leadership transition; journey towards IPO - VCs tie your personality to your startup- something to keep in mind for founders - Highs and the lows </description>
  <author_name>Lab to Startup</author_name>
  <author_url>https://labtostartup.com</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/26134866/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/147586449</thumbnail_url>
</oembed>
